Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT168 | Cell Line | P388 | Mus musculus | IC50 | = | 7 | ug/ml | 10.1021/np50053a042 |
NPT81 | Cell Line | A549 | Homo sapiens | MIC | = | 10 | ug/ml | 10.1021/np50053a042 |
NPT180 | Cell Line | HCT-8 | Homo sapiens | MIC | = | 0.1 | ug/ml | 10.1021/np50053a042 |
NPT2 | Others | Unspecified | MIC | = | 0.1 | ug/ml | 10.1021/np50053a042 | |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 8 | ug/ml | 10.1021/np50053a042 |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 209000 | nM | 12762791 |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 7.5 | ug/ml | 12444675 |
NPT85 | Organism | Filobasidiella neoformans | Cryptococcus neoformans | MIC | = | 7.5 | ug/ml | 12444675 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 7.5 | ug/ml | 12444675 |
NPT20 | Organism | Candida albicans | Candida albicans | MFC | = | 12.5 | ug/ml | 12444675 |
NPT85 | Organism | Filobasidiella neoformans | Cryptococcus neoformans | MFC | = | 12.5 | ug/ml | 12444675 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MBC | = | 12.5 | ug/ml | 12444675 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | MIC | = | 3.6 | ug/ml | 12444675 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | MIC | = | 1.8 | ug/ml | 12444675 |
NPT168 | Cell Line | P388 | Mus musculus | IC50 | = | 0.1 | ug/ml | 10217711 |
NPT2 | Others | Unspecified | IC50 | = | 8.3 | ug/ml | 10217711 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 8.1 | ug/ml | 10217711 |
NPT36 | Individual Protein | Tyrosine-protein kinase SRC | Homo sapiens | IC50 | = | 35800 | nM | 10.1039/C2MD20185B |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI | > | 20 | % | 10.1039/C2MD20185B |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | > | 20000 | nM | 10.1039/C2MD20185B |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 37200 | nM | 10.1039/C2MD20185B |
NPT784 | Cell Line | MDA-MB-468 | Homo sapiens | Activity | = | 95.65 | % | 10.1039/C2MD20185B |
NPT396 | Cell Line | T47D | Homo sapiens | Activity | = | 110.61 | % | 10.1039/C2MD20185B |
NPT457 | Cell Line | BT-549 | Homo sapiens | Activity | = | 114.49 | % | 10.1039/C2MD20185B |
NPT2 | Others | Unspecified | Activity | = | 114.35 | % | 10.1039/C2MD20185B | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Activity | = | 97.07 | % | 10.1039/C2MD20185B |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 97.84 | % | 10.1039/C2MD20185B |
NPT2 | Others | Unspecified | Activity | = | 80 | % | 10.1039/C2MD20185B | |
NPT2 | Others | Unspecified | Activity | = | 83 | % | 10.1039/C2MD20185B | |
NPT384 | Cell Line | TK-10 | Homo sapiens | Activity | = | 109.99 | % | 10.1039/C2MD20185B |
NPT368 | Cell Line | SN12C | Homo sapiens | Activity | = | 104.83 | % | 10.1039/C2MD20185B |
NPT406 | Cell Line | RXF 393 | Homo sapiens | Activity | = | 103.08 | % | 10.1039/C2MD20185B |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | Activity | = | 107 | % | 10.1039/C2MD20185B |
NPT369 | Cell Line | ACHN | Homo sapiens | Activity | = | 109.35 | % | 10.1039/C2MD20185B |
NPT376 | Cell Line | A498 | Homo sapiens | Activity | = | 87.85 | % | 10.1039/C2MD20185B |
NPT401 | Cell Line | 786-0 | Homo sapiens | Activity | = | 79.88 | % | 10.1039/C2MD20185B |
NPT2 | Others | Unspecified | Activity | = | 118.93 | % | 10.1039/C2MD20185B | |
NPT2 | Others | Unspecified | Activity | = | 98.97 | % | 10.1039/C2MD20185B | |
NPT2 | Others | Unspecified | Activity | = | 108.08 | % | 10.1039/C2MD20185B | |
NPT2 | Others | Unspecified | Activity | = | 100.35 | % | 10.1039/C2MD20185B | |
NPT2 | Others | Unspecified | Activity | = | 96.28 | % | 10.1039/C2MD20185B | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | Activity | = | 97.76 | % | 10.1039/C2MD20185B |
NPT2 | Others | Unspecified | Activity | = | 99.98 | % | 10.1039/C2MD20185B | |
NPT2 | Others | Unspecified | Activity | = | 107.12 | % | 10.1039/C2MD20185B | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | Activity | = | 97.46 | % | 10.1039/C2MD20185B |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | Activity | = | 119.18 | % | 10.1039/C2MD20185B |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | Activity | = | 147.33 | % | 10.1039/C2MD20185B |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | Activity | = | 100.32 | % | 10.1039/C2MD20185B |
NPT387 | Cell Line | M14 | Homo sapiens | Activity | = | 106 | % | 10.1039/C2MD20185B |
NPT375 | Cell Line | Malme-3M | Homo sapiens | Activity | = | 114.51 | % | 10.1039/C2MD20185B |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | Activity | = | 107.4 | % | 10.1039/C2MD20185B |
NPT75 | Cell Line | U251 | Homo sapiens | Activity | = | 102.89 | % | 10.1039/C2MD20185B |
NPT392 | Cell Line | SNB-75 | Homo sapiens | Activity | = | 94.35 | % | 10.1039/C2MD20185B |
NPT383 | Cell Line | SNB-19 | Homo sapiens | Activity | = | 98.46 | % | 10.1039/C2MD20185B |
NPT374 | Cell Line | SF-539 | Homo sapiens | Activity | = | 103.29 | % | 10.1039/C2MD20185B |
NPT399 | Cell Line | SF-295 | Homo sapiens | Activity | = | 106.62 | % | 10.1039/C2MD20185B |
NPT323 | Cell Line | SW-620 | Homo sapiens | Activity | = | 113.87 | % | 10.1039/C2MD20185B |
NPT386 | Cell Line | KM12 | Homo sapiens | Activity | = | 93.79 | % | 10.1039/C2MD20185B |
NPT139 | Cell Line | HT-29 | Homo sapiens | Activity | = | 102.73 | % | 10.1039/C2MD20185B |
NPT2 | Others | Unspecified | Activity | = | 109.18 | % | 10.1039/C2MD20185B | |
NPT2 | Others | Unspecified | Activity | = | 97.29 | % | 10.1039/C2MD20185B | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | Activity | = | 99.54 | % | 10.1039/C2MD20185B |
NPT407 | Cell Line | COLO 205 | Homo sapiens | Activity | = | 116.6 | % | 10.1039/C2MD20185B |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | Activity | = | 100.89 | % | 10.1039/C2MD20185B |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | Activity | = | 106.79 | % | 10.1039/C2MD20185B |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | Activity | = | 112.83 | % | 10.1039/C2MD20185B |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | Activity | = | 94.86 | % | 10.1039/C2MD20185B |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | Activity | = | 106.52 | % | 10.1039/C2MD20185B |
NPT372 | Cell Line | HOP-92 | Homo sapiens | Activity | = | 84.95 | % | 10.1039/C2MD20185B |
NPT379 | Cell Line | HOP-62 | Homo sapiens | Activity | = | 102.09 | % | 10.1039/C2MD20185B |
NPT2 | Others | Unspecified | Activity | = | 109.82 | % | 10.1039/C2MD20185B | |
NPT81 | Cell Line | A549 | Homo sapiens | Activity | = | 92.59 | % | 10.1039/C2MD20185B |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | Activity | = | 99.89 | % | 10.1039/C2MD20185B |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | Activity | = | 102.06 | % | 10.1039/C2MD20185B |
NPT111 | Cell Line | K562 | Homo sapiens | Activity | = | 93.03 | % | 10.1039/C2MD20185B |
NPT116 | Cell Line | HL-60 | Homo sapiens | Activity | = | 85.65 | % | 10.1039/C2MD20185B |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 104.92 | % | 10.1039/C2MD20185B |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | > | 20000 | nM | 10.1039/C2MD20185B |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | > | 50000 | nM | 10.1039/C2MD20185B |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC6597 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC79241 |
0.989 | High Similarity | NPC312132 |
0.989 | High Similarity | NPC259512 |
0.9785 | High Similarity | NPC72729 |
0.9677 | High Similarity | NPC33675 |
0.9677 | High Similarity | NPC299762 |
0.9479 | High Similarity | NPC475225 |
0.9474 | High Similarity | NPC252105 |
0.9451 | High Similarity | NPC231150 |
0.9375 | High Similarity | NPC471228 |
0.9375 | High Similarity | NPC235762 |
0.9247 | High Similarity | NPC245187 |
0.9247 | High Similarity | NPC152415 |
0.9192 | High Similarity | NPC66834 |
0.9184 | High Similarity | NPC117115 |
0.9184 | High Similarity | NPC47284 |
0.9167 | High Similarity | NPC174911 |
0.9158 | High Similarity | NPC77492 |
0.914 | High Similarity | NPC3358 |
0.914 | High Similarity | NPC162314 |
0.914 | High Similarity | NPC306884 |
0.914 | High Similarity | NPC147284 |
0.914 | High Similarity | NPC94139 |
0.914 | High Similarity | NPC210497 |
0.914 | High Similarity | NPC55903 |
0.913 | High Similarity | NPC192 |
0.9121 | High Similarity | NPC27974 |
0.91 | High Similarity | NPC64586 |
0.9091 | High Similarity | NPC21594 |
0.9091 | High Similarity | NPC53740 |
0.9091 | High Similarity | NPC310456 |
0.9072 | High Similarity | NPC477685 |
0.9032 | High Similarity | NPC306074 |
0.9032 | High Similarity | NPC304541 |
0.9011 | High Similarity | NPC407 |
0.9011 | High Similarity | NPC307235 |
0.901 | High Similarity | NPC58865 |
0.9 | High Similarity | NPC151477 |
0.8969 | High Similarity | NPC48730 |
0.8969 | High Similarity | NPC248396 |
0.8969 | High Similarity | NPC129373 |
0.8958 | High Similarity | NPC152097 |
0.8947 | High Similarity | NPC8392 |
0.8947 | High Similarity | NPC222146 |
0.8911 | High Similarity | NPC306295 |
0.8901 | High Similarity | NPC155393 |
0.8889 | High Similarity | NPC238696 |
0.8889 | High Similarity | NPC218879 |
0.8889 | High Similarity | NPC475580 |
0.8889 | High Similarity | NPC244513 |
0.8889 | High Similarity | NPC227458 |
0.8889 | High Similarity | NPC272029 |
0.8878 | High Similarity | NPC80800 |
0.8878 | High Similarity | NPC12221 |
0.8866 | High Similarity | NPC122005 |
0.8866 | High Similarity | NPC260775 |
0.8866 | High Similarity | NPC252821 |
0.8842 | High Similarity | NPC316301 |
0.8842 | High Similarity | NPC27323 |
0.8842 | High Similarity | NPC289769 |
0.8842 | High Similarity | NPC76938 |
0.8835 | High Similarity | NPC224527 |
0.8824 | High Similarity | NPC299568 |
0.8824 | High Similarity | NPC186385 |
0.8817 | High Similarity | NPC318325 |
0.8817 | High Similarity | NPC242240 |
0.8817 | High Similarity | NPC123273 |
0.8817 | High Similarity | NPC258219 |
0.8812 | High Similarity | NPC232523 |
0.8812 | High Similarity | NPC320439 |
0.8812 | High Similarity | NPC204901 |
0.8812 | High Similarity | NPC158253 |
0.88 | High Similarity | NPC37802 |
0.8791 | High Similarity | NPC150837 |
0.8791 | High Similarity | NPC286904 |
0.8788 | High Similarity | NPC269212 |
0.8788 | High Similarity | NPC108497 |
0.8776 | High Similarity | NPC70677 |
0.8776 | High Similarity | NPC130756 |
0.8776 | High Similarity | NPC12931 |
0.8776 | High Similarity | NPC225506 |
0.8763 | High Similarity | NPC156313 |
0.8763 | High Similarity | NPC474073 |
0.8763 | High Similarity | NPC475078 |
0.875 | High Similarity | NPC250323 |
0.875 | High Similarity | NPC228452 |
0.875 | High Similarity | NPC32714 |
0.8738 | High Similarity | NPC132720 |
0.8737 | High Similarity | NPC29373 |
0.8737 | High Similarity | NPC271440 |
0.8725 | High Similarity | NPC174981 |
0.8713 | High Similarity | NPC12640 |
0.8713 | High Similarity | NPC99836 |
0.8713 | High Similarity | NPC201662 |
0.871 | High Similarity | NPC19680 |
0.871 | High Similarity | NPC25493 |
0.871 | High Similarity | NPC113460 |
0.8667 | High Similarity | NPC715 |
0.8654 | High Similarity | NPC260323 |
0.8654 | High Similarity | NPC266937 |
0.8654 | High Similarity | NPC470770 |
0.8654 | High Similarity | NPC176279 |
0.8654 | High Similarity | NPC77772 |
0.8654 | High Similarity | NPC469912 |
0.8654 | High Similarity | NPC151537 |
0.8654 | High Similarity | NPC54373 |
0.8641 | High Similarity | NPC19808 |
0.8641 | High Similarity | NPC33728 |
0.8632 | High Similarity | NPC204210 |
0.8632 | High Similarity | NPC155908 |
0.8617 | High Similarity | NPC177420 |
0.8617 | High Similarity | NPC280347 |
0.8602 | High Similarity | NPC23167 |
0.86 | High Similarity | NPC24327 |
0.86 | High Similarity | NPC12870 |
0.8586 | High Similarity | NPC211885 |
0.8585 | High Similarity | NPC195922 |
0.8571 | High Similarity | NPC46940 |
0.8571 | High Similarity | NPC177962 |
0.8571 | High Similarity | NPC225464 |
0.8571 | High Similarity | NPC302371 |
0.8571 | High Similarity | NPC26615 |
0.8571 | High Similarity | NPC62867 |
0.8558 | High Similarity | NPC13482 |
0.8558 | High Similarity | NPC141782 |
0.8557 | High Similarity | NPC144682 |
0.8557 | High Similarity | NPC274678 |
0.8544 | High Similarity | NPC11554 |
0.8529 | High Similarity | NPC469913 |
0.8529 | High Similarity | NPC155072 |
0.8529 | High Similarity | NPC271274 |
0.8526 | High Similarity | NPC55561 |
0.8515 | High Similarity | NPC323810 |
0.8505 | High Similarity | NPC84999 |
0.8505 | High Similarity | NPC246760 |
0.85 | High Similarity | NPC51015 |
0.8495 | Intermediate Similarity | NPC197783 |
0.8491 | Intermediate Similarity | NPC319803 |
0.8491 | Intermediate Similarity | NPC190212 |
0.8491 | Intermediate Similarity | NPC23804 |
0.8485 | Intermediate Similarity | NPC92730 |
0.8485 | Intermediate Similarity | NPC128723 |
0.8478 | Intermediate Similarity | NPC474354 |
0.8476 | Intermediate Similarity | NPC95716 |
0.8469 | Intermediate Similarity | NPC132271 |
0.8469 | Intermediate Similarity | NPC292730 |
0.8469 | Intermediate Similarity | NPC216520 |
0.8469 | Intermediate Similarity | NPC473388 |
0.8469 | Intermediate Similarity | NPC202986 |
0.8469 | Intermediate Similarity | NPC82664 |
0.8462 | Intermediate Similarity | NPC314187 |
0.8454 | Intermediate Similarity | NPC128062 |
0.8447 | Intermediate Similarity | NPC474352 |
0.8431 | Intermediate Similarity | NPC471350 |
0.8431 | Intermediate Similarity | NPC138942 |
0.8421 | Intermediate Similarity | NPC70436 |
0.8416 | Intermediate Similarity | NPC24404 |
0.8416 | Intermediate Similarity | NPC168829 |
0.8416 | Intermediate Similarity | NPC313030 |
0.8416 | Intermediate Similarity | NPC106396 |
0.8416 | Intermediate Similarity | NPC168393 |
0.8416 | Intermediate Similarity | NPC71002 |
0.8416 | Intermediate Similarity | NPC242342 |
0.8416 | Intermediate Similarity | NPC302219 |
0.8416 | Intermediate Similarity | NPC222522 |
0.8416 | Intermediate Similarity | NPC249828 |
0.8416 | Intermediate Similarity | NPC146798 |
0.8416 | Intermediate Similarity | NPC85479 |
0.8416 | Intermediate Similarity | NPC53051 |
0.8416 | Intermediate Similarity | NPC94351 |
0.8416 | Intermediate Similarity | NPC168303 |
0.8416 | Intermediate Similarity | NPC233827 |
0.8404 | Intermediate Similarity | NPC184169 |
0.84 | Intermediate Similarity | NPC10588 |
0.84 | Intermediate Similarity | NPC130103 |
0.84 | Intermediate Similarity | NPC294741 |
0.84 | Intermediate Similarity | NPC166761 |
0.8396 | Intermediate Similarity | NPC471179 |
0.8396 | Intermediate Similarity | NPC166995 |
0.8387 | Intermediate Similarity | NPC248817 |
0.8387 | Intermediate Similarity | NPC175313 |
0.8387 | Intermediate Similarity | NPC474211 |
0.8384 | Intermediate Similarity | NPC32674 |
0.8381 | Intermediate Similarity | NPC224870 |
0.8381 | Intermediate Similarity | NPC296683 |
0.837 | Intermediate Similarity | NPC168855 |
0.8367 | Intermediate Similarity | NPC26244 |
0.835 | Intermediate Similarity | NPC477814 |
0.835 | Intermediate Similarity | NPC54765 |
0.8349 | Intermediate Similarity | NPC477136 |
0.8333 | Intermediate Similarity | NPC469719 |
0.8333 | Intermediate Similarity | NPC192948 |
0.8333 | Intermediate Similarity | NPC288411 |
0.8333 | Intermediate Similarity | NPC120719 |
0.8333 | Intermediate Similarity | NPC102216 |
0.8333 | Intermediate Similarity | NPC35797 |
0.8333 | Intermediate Similarity | NPC312304 |
0.8318 | Intermediate Similarity | NPC117846 |
0.8318 | Intermediate Similarity | NPC263753 |
0.8317 | Intermediate Similarity | NPC192032 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC6597 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.989 | High Similarity | NPD288 | Approved |
0.978 | High Similarity | NPD844 | Approved |
0.914 | High Similarity | NPD845 | Approved |
0.8969 | High Similarity | NPD289 | Clinical (unspecified phase) |
0.8842 | High Similarity | NPD1432 | Clinical (unspecified phase) |
0.8824 | High Similarity | NPD4750 | Phase 3 |
0.8673 | High Similarity | NPD3020 | Approved |
0.8571 | High Similarity | NPD7635 | Approved |
0.8557 | High Similarity | NPD1809 | Phase 2 |
0.8529 | High Similarity | NPD1444 | Approved |
0.8529 | High Similarity | NPD1445 | Approved |
0.8447 | Intermediate Similarity | NPD2342 | Discontinued |
0.8367 | Intermediate Similarity | NPD2859 | Approved |
0.8367 | Intermediate Similarity | NPD2860 | Approved |
0.8317 | Intermediate Similarity | NPD940 | Approved |
0.8317 | Intermediate Similarity | NPD846 | Approved |
0.8286 | Intermediate Similarity | NPD3021 | Approved |
0.8286 | Intermediate Similarity | NPD1792 | Phase 2 |
0.8286 | Intermediate Similarity | NPD3022 | Approved |
0.828 | Intermediate Similarity | NPD111 | Approved |
0.8265 | Intermediate Similarity | NPD2933 | Approved |
0.8265 | Intermediate Similarity | NPD2934 | Approved |
0.7838 | Intermediate Similarity | NPD6671 | Approved |
0.7788 | Intermediate Similarity | NPD3091 | Approved |
0.7748 | Intermediate Similarity | NPD1791 | Approved |
0.7748 | Intermediate Similarity | NPD1793 | Approved |
0.7714 | Intermediate Similarity | NPD9500 | Approved |
0.7692 | Intermediate Similarity | NPD4749 | Approved |
0.7692 | Intermediate Similarity | NPD1242 | Phase 1 |
0.7658 | Intermediate Similarity | NPD2228 | Approved |
0.7658 | Intermediate Similarity | NPD2229 | Approved |
0.7658 | Intermediate Similarity | NPD2234 | Approved |
0.7652 | Intermediate Similarity | NPD3019 | Approved |
0.7652 | Intermediate Similarity | NPD2932 | Approved |
0.7652 | Intermediate Similarity | NPD4626 | Approved |
0.7652 | Intermediate Similarity | NPD1751 | Approved |
0.7652 | Intermediate Similarity | NPD4059 | Approved |
0.7632 | Intermediate Similarity | NPD2226 | Clinical (unspecified phase) |
0.7611 | Intermediate Similarity | NPD7325 | Clinical (unspecified phase) |
0.7589 | Intermediate Similarity | NPD497 | Approved |
0.7565 | Intermediate Similarity | NPD4093 | Discontinued |
0.7542 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.7521 | Intermediate Similarity | NPD3092 | Approved |
0.75 | Intermediate Similarity | NPD9273 | Approved |
0.75 | Intermediate Similarity | NPD495 | Approved |
0.75 | Intermediate Similarity | NPD498 | Approved |
0.75 | Intermediate Similarity | NPD496 | Approved |
0.7478 | Intermediate Similarity | NPD5304 | Approved |
0.7478 | Intermediate Similarity | NPD5303 | Approved |
0.7477 | Intermediate Similarity | NPD228 | Approved |
0.7477 | Intermediate Similarity | NPD6124 | Clinical (unspecified phase) |
0.7477 | Intermediate Similarity | NPD9610 | Approved |
0.7477 | Intermediate Similarity | NPD9608 | Approved |
0.7473 | Intermediate Similarity | NPD9087 | Approved |
0.7434 | Intermediate Similarity | NPD1476 | Clinical (unspecified phase) |
0.7383 | Intermediate Similarity | NPD5700 | Clinical (unspecified phase) |
0.7373 | Intermediate Similarity | NPD1201 | Approved |
0.7373 | Intermediate Similarity | NPD5351 | Clinical (unspecified phase) |
0.7373 | Intermediate Similarity | NPD5350 | Clinical (unspecified phase) |
0.7355 | Intermediate Similarity | NPD6917 | Clinical (unspecified phase) |
0.735 | Intermediate Similarity | NPD2286 | Discontinued |
0.735 | Intermediate Similarity | NPD3095 | Discontinued |
0.735 | Intermediate Similarity | NPD4589 | Approved |
0.7345 | Intermediate Similarity | NPD1398 | Phase 1 |
0.7345 | Intermediate Similarity | NPD7159 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD6696 | Suspended |
0.7317 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7311 | Intermediate Similarity | NPD2233 | Approved |
0.7311 | Intermediate Similarity | NPD2230 | Approved |
0.7311 | Intermediate Similarity | NPD2232 | Approved |
0.7304 | Intermediate Similarity | NPD7340 | Approved |
0.7304 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7288 | Intermediate Similarity | NPD1983 | Approved |
0.7288 | Intermediate Similarity | NPD1980 | Approved |
0.7288 | Intermediate Similarity | NPD1981 | Approved |
0.7281 | Intermediate Similarity | NPD9618 | Approved |
0.7281 | Intermediate Similarity | NPD9614 | Approved |
0.7273 | Intermediate Similarity | NPD3094 | Phase 2 |
0.7265 | Intermediate Similarity | NPD5691 | Approved |
0.7258 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7257 | Intermediate Similarity | NPD9379 | Approved |
0.7257 | Intermediate Similarity | NPD9377 | Approved |
0.7234 | Intermediate Similarity | NPD9294 | Approved |
0.7217 | Intermediate Similarity | NPD709 | Approved |
0.7213 | Intermediate Similarity | NPD2194 | Approved |
0.7213 | Intermediate Similarity | NPD2195 | Approved |
0.7203 | Intermediate Similarity | NPD1778 | Approved |
0.7196 | Intermediate Similarity | NPD1616 | Discontinued |
0.7196 | Intermediate Similarity | NPD3028 | Approved |
0.7193 | Intermediate Similarity | NPD5283 | Phase 1 |
0.7158 | Intermediate Similarity | NPD9088 | Approved |
0.7154 | Intermediate Similarity | NPD5736 | Approved |
0.7154 | Intermediate Similarity | NPD3636 | Approved |
0.7154 | Intermediate Similarity | NPD3637 | Approved |
0.7154 | Intermediate Similarity | NPD3635 | Approved |
0.7154 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7131 | Intermediate Similarity | NPD1470 | Approved |
0.713 | Intermediate Similarity | NPD475 | Phase 2 |
0.7129 | Intermediate Similarity | NPD1101 | Approved |
0.7117 | Intermediate Similarity | NPD290 | Approved |
0.7107 | Intermediate Similarity | NPD1755 | Approved |
0.7105 | Intermediate Similarity | NPD1138 | Approved |
0.7097 | Intermediate Similarity | NPD2605 | Approved |
0.7097 | Intermediate Similarity | NPD2606 | Approved |
0.7094 | Intermediate Similarity | NPD9615 | Approved |
0.7094 | Intermediate Similarity | NPD9613 | Approved |
0.7094 | Intermediate Similarity | NPD9616 | Approved |
0.7083 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7054 | Intermediate Similarity | NPD2684 | Approved |
0.7049 | Intermediate Similarity | NPD1283 | Approved |
0.704 | Intermediate Similarity | NPD5156 | Approved |
0.704 | Intermediate Similarity | NPD5155 | Approved |
0.7034 | Intermediate Similarity | NPD7330 | Discontinued |
0.7034 | Intermediate Similarity | NPD316 | Approved |
0.7031 | Intermediate Similarity | NPD4097 | Suspended |
0.7027 | Intermediate Similarity | NPD968 | Approved |
0.7018 | Intermediate Similarity | NPD1137 | Approved |
0.7018 | Intermediate Similarity | NPD1139 | Approved |
0.7016 | Intermediate Similarity | NPD1712 | Approved |
0.7008 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7 | Intermediate Similarity | NPD3023 | Approved |
0.7 | Intermediate Similarity | NPD3026 | Approved |
0.7 | Intermediate Similarity | NPD3496 | Discontinued |
0.6992 | Remote Similarity | NPD4339 | Clinical (unspecified phase) |
0.6991 | Remote Similarity | NPD9380 | Clinical (unspecified phase) |
0.699 | Remote Similarity | NPD1089 | Approved |
0.699 | Remote Similarity | NPD1090 | Approved |
0.699 | Remote Similarity | NPD1086 | Approved |
0.6975 | Remote Similarity | NPD3025 | Approved |
0.6975 | Remote Similarity | NPD1651 | Approved |
0.6975 | Remote Similarity | NPD3024 | Approved |
0.6975 | Remote Similarity | NPD4235 | Clinical (unspecified phase) |
0.6975 | Remote Similarity | NPD4196 | Clinical (unspecified phase) |
0.6972 | Remote Similarity | NPD4818 | Approved |
0.6972 | Remote Similarity | NPD4817 | Approved |
0.696 | Remote Similarity | NPD3595 | Approved |
0.696 | Remote Similarity | NPD3594 | Approved |
0.696 | Remote Similarity | NPD4908 | Phase 1 |
0.6942 | Remote Similarity | NPD1611 | Approved |
0.6935 | Remote Similarity | NPD4624 | Approved |
0.693 | Remote Similarity | NPD9280 | Clinical (unspecified phase) |
0.6929 | Remote Similarity | NPD6663 | Approved |
0.6923 | Remote Similarity | NPD7157 | Approved |
0.6923 | Remote Similarity | NPD256 | Approved |
0.6923 | Remote Similarity | NPD255 | Approved |
0.6917 | Remote Similarity | NPD2667 | Approved |
0.6917 | Remote Similarity | NPD2668 | Approved |
0.6917 | Remote Similarity | NPD5238 | Clinical (unspecified phase) |
0.6903 | Remote Similarity | NPD9266 | Approved |
0.6903 | Remote Similarity | NPD74 | Approved |
0.6893 | Remote Similarity | NPD800 | Approved |
0.6891 | Remote Similarity | NPD1759 | Phase 1 |
0.6887 | Remote Similarity | NPD1693 | Approved |
0.6885 | Remote Similarity | NPD1608 | Approved |
0.687 | Remote Similarity | NPD6099 | Approved |
0.687 | Remote Similarity | NPD6100 | Approved |
0.6869 | Remote Similarity | NPD9089 | Approved |
0.6864 | Remote Similarity | NPD7636 | Approved |
0.6864 | Remote Similarity | NPD9493 | Approved |
0.686 | Remote Similarity | NPD2688 | Clinical (unspecified phase) |
0.686 | Remote Similarity | NPD3143 | Discontinued |
0.6857 | Remote Similarity | NPD1088 | Approved |
0.6855 | Remote Similarity | NPD2797 | Approved |
0.685 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6847 | Remote Similarity | NPD9244 | Approved |
0.6846 | Remote Similarity | NPD7718 | Clinical (unspecified phase) |
0.6814 | Remote Similarity | NPD9263 | Approved |
0.6814 | Remote Similarity | NPD9264 | Approved |
0.6814 | Remote Similarity | NPD9267 | Approved |
0.681 | Remote Similarity | NPD821 | Approved |
0.681 | Remote Similarity | NPD7843 | Approved |
0.6807 | Remote Similarity | NPD16 | Approved |
0.6807 | Remote Similarity | NPD856 | Approved |
0.6807 | Remote Similarity | NPD1758 | Phase 1 |
0.6803 | Remote Similarity | NPD1281 | Approved |
0.68 | Remote Similarity | NPD6584 | Phase 3 |
0.6794 | Remote Similarity | NPD3299 | Clinical (unspecified phase) |
0.6792 | Remote Similarity | NPD1409 | Phase 3 |
0.678 | Remote Similarity | NPD6387 | Discontinued |
0.6777 | Remote Similarity | NPD9381 | Approved |
0.6777 | Remote Similarity | NPD9384 | Approved |
0.6768 | Remote Similarity | NPD9093 | Approved |
0.6767 | Remote Similarity | NPD4257 | Approved |
0.6767 | Remote Similarity | NPD4256 | Phase 2 |
0.6757 | Remote Similarity | NPD4229 | Approved |
0.6757 | Remote Similarity | NPD3680 | Approved |
0.6757 | Remote Similarity | NPD4231 | Approved |
0.6757 | Remote Similarity | NPD3683 | Approved |
0.6757 | Remote Similarity | NPD3682 | Approved |
0.6757 | Remote Similarity | NPD3681 | Approved |
0.6752 | Remote Similarity | NPD4869 | Clinical (unspecified phase) |
0.675 | Remote Similarity | NPD1548 | Phase 1 |
0.6748 | Remote Similarity | NPD3070 | Discontinued |
0.6748 | Remote Similarity | NPD2231 | Phase 2 |
0.6748 | Remote Similarity | NPD2235 | Phase 2 |
0.6746 | Remote Similarity | NPD2237 | Approved |
0.6744 | Remote Similarity | NPD3619 | Clinical (unspecified phase) |
0.6744 | Remote Similarity | NPD6346 | Approved |
0.6744 | Remote Similarity | NPD3620 | Phase 2 |
0.6744 | Remote Similarity | NPD2238 | Phase 2 |
PubChem CID   | 156118 |
ChEMBL   | CHEMBL451860 |
ZINC   |
Molecular Weight:   | 218.17 |
ALogP:   | 2.3825 |
MLogP:   | 3 |
XLogP:   | 5.483 |
# Rotatable Bonds:   | 9 |
Polar Surface Area:   | 20.23 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 1 |
# Rings:   | 1 |
# Heavy Atoms:   | 16 |